Cardiogenic Shock

• FDA approval · 2025-03-21
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (BIOCON PHARMA INC.)

  FDA approved Biocon Pharma Inc. for an Original Application of norepinephrine bitartrate (norepinephrine bitartrate) as a generic product. I…

• FDA approval · 2025-01-31
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approves Camber Pharmaceuticals' norepinephrine bitartrate as an original application (generic) product.

• FDA approval · 2024-11-05
  FDA Approved: DOPAMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for dopamine hydrochloride injectable from Hikma Pharmaceuticals USA Inc., confirming continued appr…

• FDA approval · 2024-10-03
  FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)

  FDA approved an original ANDA for Isoproterenol hydrochloride from Sagent Pharmaceuticals.

• FDA approval · 2024-08-22
  FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)

  FDA approved a supplemental application for isoproterenol hydrochloride from Amneal Pharmaceuticals LLC. The action expands the approved use…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2024-06-11
  FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for norepinephrine bitartrate from Baxter Healthcare Corporation.

• FDA approval · 2024-03-06
  FDA Approved: DOBUTAMINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for the dobutamine product from Hikma Pharmaceuticals USA Inc.

• FDA approval · 2023-09-08
  FDA Approved: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE (Baxter).

• FDA approval · 2022-12-21
  FDA Approved: DOBUTAMINE — Original Application (Slate Run Pharmaceuticals)

  FDA approves Slate Run Pharmaceuticals' dobutamine—Original Application (ANDA 216131)—granting approval of a generic dobutamine product. Thi…

• FDA approval · 2022-09-15
  FDA Approved: NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)

  FDA approves norepinephrine bitartrate in sodium chloride for injection under an original application by WG Critical Care, LLC, a vasopresso…

• FDA approval · 2019-05-24
  FDA Approved: DOBUTAMINE IN DEXTROSE — Supplemental Application (Hospira, Inc.)

  FDA approved a supplemental application for Dobutamine in Dextrose from Hospira, Inc.

• FDA approval · 2016-05-31
  FDA Approved: DOBUTAMINE IN DEXTROSE — Supplemental Application (Hospira, Inc.)

  The FDA approved a supplemental application for Dobutamine in Dextrose from Hospira, Inc., adding a new formulation to the product’s approve…

• FDA approval · 2013-04-17
  FDA Approved: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved Baxter Healthcare's supplemental application for dobutamine hydrochloride in dextrose. The approval covers the dobutamine hydro…

• FDA approval · 2012-03-05
  FDA Approved: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for Dobutamine Hydrochloride in Dextrose, a Baxter product, indicating an approved change or additio…